Why Not Sequence the Whole Genome?
Professor René Bernards, Head of the Division/Group Leader, Molecular Carcinogenesis at The Netherlands Cancer Institute, joins Andrea Charles from Pharma IQ, to discuss current trends in next-generation DNA sequencing in oncology research, industry uptake of next-generation DNA sequencing technologies, the advantages of enriching and true commercial potential of personalised medicine. Have Your Say Rate this feature and give us your feedback in the comments section below
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.